Mina, Ashraf <br/><br/>
Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.  [electronic resource] 

 -  Seminars in thrombosis and hemostasis  Nov 2007 
 - 798-809 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0094-6176 
<br/><br/><label>Standard No.: </label>10.1055/s-2007-1000372  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Platelets--metabolism<br/>C-Reactive Protein--metabolism<br/>Cardiovascular Diseases--blood<br/>Cell Adhesion Molecules--metabolism<br/>Diabetes Complications--blood<br/>Endocrine System Diseases--blood<br/>Endothelial Cells--metabolism<br/>Hemostasis<br/>Hemostatic Disorders--blood<br/>Humans<br/>Insulin Resistance<br/>Insulin-Like Growth Factor I--metabolism<br/>Nitric Oxide--blood<br/>Oxidative Stress<br/>Plasminogen Activator Inhibitor 1--blood<br/>Risk Factors<br/>Serotonin--blood<br/>von Willebrand Diseases--blood<br/>von Willebrand Factor--metabolism